Results 141 to 150 of about 53,648 (262)
Revista Cubana de Oftalmología, 2009 INTRODUCCIÓN: La prevalencia de la retinopatía diabética está determinada por el tipo de diabetes mellitus y por el tiempo de evolución de la enfermedad.
Eddy Mesa Hernández +4 more
doaj
Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates
, 2014 Sohee Jeon, Won Ki LeeDepartment of Ophthalmology, Seoul St Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, KoreaBackground: We evaluated the efficacy of intravitreal bevacizumab on diabetic macular edema with ...
Jeon S, Lee WK
core
Journal of Biophotonics, Volume 19, Issue 6, June 2026.A scanning laser ophthalmoscope, integrated with a real‐time optical coherence tomography (OCT) alignment monitor, detected flavoprotein fluorescence (FPF) signals associated with mitochondrial dysfunction in a rodent glaucoma model. Under 450‐nm excitation, experimental eyes showed spatially inhomogeneous signals that were absent under 505‐nm ...
Eun Ji Lee +5 more
wiley +1 more source
Clinical outcomes of ranibizumab treatment in diabetic eye disease
, 2015 Background: The vascular endothelial growth factor (VEGF) inhibitor ranibizumab is emerging as an efficacious treatment for diabetic macular oedema. Large clinical trials have shown improvements in visual acuity and reduced central retinal thickness ...
Comyn, OJ
core
Allergic Contact Dermatitis From Dorzolamide Without Cross‐Reactivity to Brinzolamide
Contact Dermatitis, Volume 95, Issue 1, Page 116-117, July 2026.
Elias Ghozli +4 more
wiley +1 more source
The Kaohsiung Journal of Medical Sciences, Volume 42, Issue 6, June 2026.ABSTRACT Diabetic retinopathy (DR) is a leading cause of vision impairment in patients diagnosed with Type 2 diabetes mellitus (T2DM). Awareness of risk factors is necessary to reduce or prevent harmful effects of DR such as irreversible vision loss, and to help ensure early treatment.
Yu‐Chi Sung +8 more
wiley +1 more source
, 2016 Lavnish Joshi,1–3 Asaf Bar,4 Oren Tomkins-Netzer,1,3 Satish Yaganti,1 Jiten Morarji,1 Panayiotis Vouzounis,1 Sophie Seguin-Greenstein,1,4 Simon R Taylor,3,5 Sue Lightman1,3 1Department of Clinical Ophthalmology, UCL Institute of Ophthalmology and ...
Tomkins-Netzer O +8 more
core
Acta Ophthalmologica, Volume 104, Issue 4, Page 402-409, June 2026.Abstract Purpose To compare the inflammatory response in the eye after trabeculectomy to after phacoemulsification, focusing on anterior chamber flare (AC flare) and central macular thickness (CMT). Methods Data from 436 participants in two randomized controlled trials were analysed.
Yasmeen Ahmed +5 more
wiley +1 more source
Acta Ophthalmologica, Volume 104, Issue 4, Page e406-e415, June 2026.Abstract Purpose This study characterized and assessed vision‐related quality of life (VRQoL) in patients with neovascular age‐related macular degeneration (nAMD) who discontinued treatment with intravitreal anti‐vascular endothelial growth factor (anti‐VEGF), comparing them to those undergoing treatment.
Noreddin Shekho +4 more
wiley +1 more source
Clinical Ophthalmology, 2014 Teruyo Kida, Seita Morishita, Keigo Kakurai, Hiroyuki Suzuki, Hidehiro Oku, Tsunehiko IkedaDepartment of Ophthalmology, Osaka Medical College, Osaka, JapanBackground: We report our findings in three cases of unilateral macular edema associated with ...
Kida T +5 more
doaj